RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
🏥 Up to 12% of all positive cases required ICU admission Complications: •ARDS: 60–70% •Shock: 30% •Myocardial dysfunction: 20–30% •Acute kidney injury: 10–30% https://t.co/9WhGIWQgI2
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
https://t.co/FvxRGsOAiP Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
@daniyal_asim
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @2itstar: Simple y al grano, de mucha utilidad para nuestros médicos. Cada día vamos construyendo más sobre los hombros de los demás paí…
@maddow 👇
@JohnNosta please take a look
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
How to mange patients in ICU: a review
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
محتوى جميل و شيّق بارك الله فيك على حرصك في طرح مستجدات #كورونا_الجديد @biohussein 🌹
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU ... وهل يجب إعطاء الادوية المثبطة للسيتوكين (مثبطات الجهاز المناعي) لمنع الالتهاب الرئوي ؟ المصدر: https://t.co/j3GXvNDXcL https://t
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations @TheLancet https://t.co/jchFc7WWxl
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations (open access) https://t.co/HleGUxvNLu
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Simple y al grano, de mucha utilidad para nuestros médicos. Cada día vamos construyendo más sobre los hombros de los demás países
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blockers be given to prevent pneumonia or decompensation? https://t.co/11ArlQau85 @TheLancetRheum https://t.co/PjUJxXcC98
2019年冠狀病毒病的重症監護管理(COVID-19):挑戰和建議 https://t.co/1OsLT48YEL
Challenges and recommendations for #COVID19 from the intensive care perspective #ICU Congrats @LingLing7 @CUHKMedicine!
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @CUHKMedicine https://t.co/YCx3m4SgPp